Mostrar el registro sencillo del ítem

Autordc.contributor.authorDanilla, Stefan V. 
Autordc.contributor.authorJara, Rocío P. 
Autordc.contributor.authorMiranda, Felipe 
Autordc.contributor.authorBencina, Francisco 
Autordc.contributor.authorAguirre, Marcela 
Autordc.contributor.authorTroncoso, Ekaterina 
Autordc.contributor.authorErazo, Cristian A. 
Autordc.contributor.authorAndrades, Patricio R. 
Autordc.contributor.authorSepúlveda, Sergio L. 
Autordc.contributor.authorAlbornoz, Claudia R. 
Fecha ingresodc.date.accessioned2021-08-04T23:05:36Z
Fecha disponibledc.date.available2021-08-04T23:05:36Z
Fecha de publicacióndc.date.issued2020
Cita de ítemdc.identifier.citationAesthetic Surgery Journal 2020, Vol 40(7) 721–731es_ES
Identificadordc.identifier.other10.1093/asj/sjz343
Identificadordc.identifier.urihttps://repositorio.uchile.cl/handle/2250/181093
Resumendc.description.abstractBackground: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an emergent disease that threatens patients with texturized breast implants. Major concerns about the safety of these implants are leading to global changes to restrict the utilization of this product. The principal alternative is to perform breast augmentation utilizing smooth implants, given the lack of association with BIA-ALCL. The implications and costs of this intervention are unknown. Objectives: The authors of this study determined the cost-effectiveness of smooth implants compared with texturized implants for breast augmentation surgery. Methods: A tree decision model was utilized to analyze the cost-effectiveness. Model input parameters were derived from published sources. The capsular contracture (CC) rate was calculated from a meta-analysis. Effectiveness measures were life years, avoided BIA-ALCL, avoided deaths, and avoided reoperations. A sensitivity analysis was performed to test the robustness of the model. Results: For avoided BIA-ALCL, the incremental cost was $18,562,003 for smooth implants over texturized implants. The incremental cost-effectiveness ratio was negative for life years, and avoided death and avoided reoperations were negative. The sensitivity analysis revealed that to avoid 1 case of BIA-ALCL, the utilization of smooth implants would be cost-effective for a risk of developing BIA-ALCL equal to or greater than 1:196, and there is a probability of CC with smooth implants equal to or less than 0.096. Conclusions: The utilization of smooth implants to prevent BIA-ALCL is not cost-effective. Banning texturized implants to prevent BIA-ALCL may involve additional consequences, which should be considered in light of higher CC rates and more reoperations associated with smooth implants than with texturized implants.es_ES
Idiomadc.language.isoenes_ES
Publicadordc.publisherOxford University Presses_ES
Tipo de licenciadc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link a Licenciadc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Fuentedc.sourceAesthetic Surgery Journales_ES
Palabras clavesdc.subjectPovidone-iodine irrigationes_ES
Palabras clavesdc.subjectCapsular contracturees_ES
Palabras clavesdc.subjectSmooth implantses_ES
Palabras clavesdc.subjectLong-termes_ES
Palabras clavesdc.subjectAugmentationes_ES
Palabras clavesdc.subjectEpidemiologyes_ES
Palabras clavesdc.subjectRiskes_ES
Palabras clavesdc.subjectAlcles_ES
Títulodc.titleIs banning texturized implants to prevent breast implant-associated anaplastic large cell lymphoma a rational decision? A meta-analysis and cost-effectiveness studyes_ES
Tipo de documentodc.typeArtículo de revistaes_ES
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogadoruchile.catalogadorcfres_ES
Indizaciónuchile.indexArtículo de publicación ISI
Indizaciónuchile.indexArtículo de publicación SCOPUS


Descargar archivo

Icon

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 3.0 Chile
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 3.0 Chile